Analysis of risk factors for multiple drug resistant bacterial infections in chronic obstructive pulmonary disease
10.11958/20150111
- VernacularTitle:慢性阻塞性肺疾病多重耐药菌感染的危险因素分析
- Author:
Zhaoyun XIE
;
Yun XIONG
;
Jing SUN
;
Yang HU
;
Yaofu LI
- Publication Type:Journal Article
- Keywords:
pulmonary disease,chronic obstructive;
risk factors;
pulmonary infection;
multidrug-resistant;
Logistic regression analysis
- From:
Tianjin Medical Journal
2016;44(6):744-747
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the risk factors of multiple drug resistant bacterial infections in patients with chronic obstructive pulmonary disease (COPD), and provide guidance for disease control and prevention. Methods Clinical data of 814 COPD patients were retrospectively analyzed from June 2011 to May 2015, including patient's age, gender, smoking history, age of onset, severity, aggravated frequency, duration of exacerbations, diabetes mellitus, complications, use frequency and use duration of glucocorticoid, use frequency of antimicrobial agents and use duration of each time, types of antimicrobial drugs used, combined with antibacterial drugs, plasma albumin concentration, blood glucose, bacteria culture detection of multi drug resistant bacteria infection. The risk factors of multi drug resistant bacteria infection were analyzed. Results A total of 857 pathogenic bacteria were isolated from 814 COPD patients with pulmonary infection. Multiple drug resistant bacteria infection were detected in 170 cases, and 175 strains (20.42%) were detected. The detection rate of multi drug resistant/PAN resistant pseudomonas aeruginosa (MDR/PDR-PA) was 55.38% (36/65). There were significant differences in patients with multi drug resistant bacteria infection between different clinical pathological characteristics. Logistic regression analysis showed that the acute exacerbation duration (days), long time use of antimicrobial drugs, and high frequency of corticosteroids and antibiotics use were independent risk factor of multi drug resistant bacteria infection in COPD patients. Conclusion Prevention and treatment of multiple drug resistant bacteria infection in COPD patients should pay attention to the combination of community and hospital, and take effective measures to prevent and control the risk factors.
